Lupus
Overview
Lupus is a peer-reviewed medical journal dedicated to advancing the understanding and management of systemic lupus erythematosus and related autoimmune diseases. It publishes high-quality research articles, reviews, and case reports, covering various aspects of lupus, including clinical manifestations, pathogenesis, diagnosis, treatment, and patient outcomes. With its interdisciplinary approach, Lupus serves as a valuable resource for healthcare professionals, researchers, and patients seeking the latest advancements in lupus research and care.
Details
Details
Abbr.
Lupus
Publisher
Sage Publications
Start
1991
End
Continuing
Frequency
Fourteen no. a year, 2009-
p-ISSN
0961-2033
e-ISSN
1477-0962
Country
United Kingdom
Language
English
Specialty
Rheumatology
Metrics
Metrics
h-index / Ranks: 2309
118
SJR / Ranks: 5158
812
CiteScore / Ranks: 6169
4.30
JIF / Ranks: 4138
2.6
Recent Articles
1.
Cheung C, Mok C
Lupus
. 2025 Mar;
:9612033251326987.
PMID: 40083183
BackgroundLong COVID was defined by the WHO as continuation or development of new symptoms 3 months after the initial SARS-CoV2 infection, with these symptoms lasting for ≥2 months without alternative...
2.
Caruso Mazzolani B, Infante Smaira F, Mendes Sieczkowska S, Romero M, C Santo Andre H, G Pasoto S, et al.
Lupus
. 2025 Mar;
:9612033251326986.
PMID: 40083122
Despite the beneficial effects of a healthier lifestyle, lack of more robust data hampers standardization of recommendations for patients with systemic lupus erythematosus (SLE). Thus, this study explores the experiences,...
3.
Ugarte-Gil M, Gamboa-Cardenas R, Pimentel-Quiroz V, Reategui-Sokolova C, Elera-Fitzcarrald C, Zevallos F, et al.
Lupus
. 2025 Mar;
:9612033251325320.
PMID: 40067209
To determine the possible predictive value of self-efficacy on fatigue in SLE patients. SLE patients from a single-center prevalent cohort were included. Self-efficacy was ascertained with the five instruments of...
4.
Olaosebikan H, Yerima A, Odunlami G, Uhunmwangho C, Nwankwo H, Kofar Naisa M, et al.
Lupus
. 2025 Mar;
:9612033251324482.
PMID: 40037381
Background: Although there is an increase in prevalence and incidence of lupus worldwide, the journey to diagnosis is unduly delayed. This delay is associated with worse outcomes. Sub-Saharan Africa has...
5.
Rodelo-Ceballos J, Aguirre L, Gonzalez L
Lupus
. 2025 Mar;
:9612033251325315.
PMID: 40035154
Objective: To assess the effectiveness of the modified National Institute of Health (mNIH) activity and chronicity scoring system in predicting the progression to end-stage kidney disease (ESKD) in Latin American...
6.
Aslan E, Sahin S, Bektas S, Akay N, Gul U, Kilic Konte E, et al.
Lupus
. 2025 Mar;
:9612033251325321.
PMID: 40035114
Objective: Classification criteria for systemic lupus erythematosus (SLE) are required to ensure consistency in enrolling patients into clinical trials. We aimed to evaluate the performance of the 2019 European League...
7.
Nadarajah L, Bonthrone C, Pakozdi A, Pyne D, Cove-Smith A, Rajakariar R
Lupus
. 2025 Mar;
:9612033251325297.
PMID: 40029832
No abstract available.
8.
Tangkittiwet N, Charuvanij S, Manaboriboon B, Chantaratin S, Pattaragarn A, Piyaphanee N
Lupus
. 2025 Mar;
:9612033251325313.
PMID: 40024907
Background: The illness perception and mental health in Systemic Lupus Erythematosus (SLE) is acknowledged. However, the link between illness perceptions and psychological issues in adolescents with SLE remains unclear. This...
9.
Ma J, Zhang L, Yan M, Lu C, Xue L
Lupus
. 2025 Mar;
:9612033251324467.
PMID: 40024906
Objectives: To investigate the clinical characteristics of patients with systemic lupus erythematosus (SLE) with positive anti-ribosomal P protein antibodies and the associated risk factors in a larger sample size. Methods:...
10.
Illness experience and authorship of life in a "transplanted person" with Lupus: A DIPEx perspective
Victor Luna J, Assis Pinheiro M, Navarro Dias de Souza A
Lupus
. 2025 Feb;
:9612033251324498.
PMID: 40015567
We present a case of a 37 yo woman who underwent a heart and kidney transplantation due to Lupus and has had a 10-year follow-up without significant complications or Lupus...